Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection

Carolyn V. Gould, Jonathan R. Edwards, Jessica Cohen, Wendy M. Bamberg, Leigh Ann Clark, Monica M. Farley, Helen Johnston, Joelle Nadle, Lisa Winston, Dale N. Gerding, L. Clifford McDonald, Fernanda C. Lessa, Zintars Beldavs, Samir Hanna, Gary Hollick, Stacy Holzbauer, Carol Lyons, Erin Phipps, Lucy Wilson

Research output: Contribution to journalArticlepeer-review

Abstract

Nucleic acid amplification testing (NAAT) is increasingly being adopted for diagnosis of Clostridium difficile infection (CDI). Data from 3 states conducting population-based CDI surveillance showed increases ranging from 43% to 67% in CDI incidence attributable to changing from toxin enzyme immunoassays to NAAT. CDI surveillance requires adjustment for testing methods.

Original languageEnglish (US)
Pages (from-to)1304-1307
Number of pages4
JournalClinical Infectious Diseases
Volume57
Issue number9
DOIs
StatePublished - Nov 1 2013

Keywords

  • clinical laboratory techniques
  • Clostridium difficile
  • incidence
  • nucleic acid amplification techniques
  • surveillance

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Effect of nucleic acid amplification testing on population-based incidence rates of clostridium difficile infection'. Together they form a unique fingerprint.

Cite this